Marketing Agreements in the Biotechnology Industry
23 Contracts & Agreements
- Acorda Therapeutics (2 contracts)
- AMARILLO BIOSCIENCES INC (1)
- ARENA PHARMACEUTICALS INC (2)
- ATOSSA GENETICS INC (1)
- Axovant Sciences Ltd. (2)
- Biogen Inc. (1)
- CYTRX CORP (1)
- Emergent BioSolutions Inc. (2)
- Environmental Impact Acquisition Corp (2)
- ENZON PHARMACEUTICALS, INC. (1)
- Invitae Corp (1)
- Medovex Corp. (1)
- NantKwest, Inc. (1)
- Petra Acquisition Inc. (3)
- Protagenic Therapeutics, Inc. (1)
- SELLAS Life Sciences Group, Inc. (1)
- Business Combination Marketing Agreement, by and among the Company and Canaccord Genuity LLC (Environmental Impact Acquisition Corp, Filed With SEC on January 20, 2021)
- Form of Business Combination Marketing Agreement between the Registrant and Canaccord Genuity LLC (Environmental Impact Acquisition Corp, Filed With SEC on January 11, 2021)
- COVID Joint Development, Manufacturing and Marketing Agreement between NantKwest, Inc. and ImmunityBio, Inc., dated August 21, 2020 (NantKwest, Inc., Filed With SEC on November 9, 2020)
- Business Combination Marketing Agreement, dated October 7, 2020, by and among the Company, LifeSci Capital LLC, Ladenburg Thalmann & Co. Inc., Northland Securities, Inc., and... (Petra Acquisition Inc., Filed With SEC on October 13, 2020)
- Form of Business Combination Marketing Agreement (Petra Acquisition Inc., Filed With SEC on August 26, 2020)
- Form of Business Combination Marketing Agreement (Petra Acquisition Inc., Filed With SEC on July 29, 2020)
- Amended and Restated Exclusive IP Marketing Agreement, dated as of June 28, 2004, by and between Microment AG and Enzon Pharmaceuticals, Inc (ENZON PHARMACEUTICALS, INC., Filed With SEC on February 21, 2019)
- Letter Agreement, dated October 18, 2017, re: Non-Commercial Manufacturing Provisions of the Development, Marketing and Supply Agreement, dated May 8, 2015, by and between Arena... (Axovant Sciences Ltd., Filed With SEC on November 2, 2017)
- Marketing and Laboratory Services Agreement dated as of September 25, 2017 by and between Invitae Corporation, Good Start Genetics, Inc. and CombiMatrix Molecular Diagnostics, Inc (Invitae Corp, Filed With SEC on September 27, 2017)
- Development, Marketing and Supply Agreement by and between Arena Pharmaceuticals GmbH and Roivant Sciences Ltd. dated May 8, 2015 (Axovant Sciences Ltd., Filed With SEC on February 9, 2016)
- MARKETING AGREEMENT (Medovex Corp., Filed With SEC on May 11, 2015)
- CONFIDENTIAL TREATMENT REQUESTED BY ATOSSAGENETICS INC. THE USE OF THE FOLLOWING NOTATION INTHIS EXHIBIT INDICATES THAT A CONFIDENTIAL PORTION HAS BEEN OMITTED PURSUANT TO A... (ATOSSA GENETICS INC, Filed With SEC on November 12, 2014)
- Second Amended and Restated Marketing and Supply Agreement by and among ArenaPharmaceuticals GmbH, Eisai Inc., and Eisai Co., Ltd. dated November 7, 2013 (ARENA PHARMACEUTICALS INC, Filed With SEC on March 3, 2014)
- LICENCE AND SUPPLY AGREEMENT by and between GALENA BIOPHARMA INC of 310 State Street, Suite 208, Lake Oswego, OR 97034, USA (Galena) and ABIC MARKETING LIMITED of Hateena 1,... (SELLAS Life Sciences Group, Inc., Filed With SEC on March 12, 2013)
- Amended and Restated Marketing and Supply Agreement by and between Arena Pharmaceuticals GmbH and Eisai Inc. dated May 9, 2012 TABLE OF CONTENTS (ARENA PHARMACEUTICALS INC, Filed With SEC on August 9, 2012)
- Investor Direct Marketing Services Agreement (AMARILLO BIOSCIENCES INC, Filed With SEC on May 21, 2008)
- MARKETING AGREEMENT BY AND BETWEEN BUONGIORNO USA, INC. AND (Protagenic Therapeutics, Inc., Filed With SEC on February 13, 2007)
- AMENDED AND RESTATED MARKETING AGREEMENT (Emergent BioSolutions Inc., Filed With SEC on September 25, 2006)
- AMENDED AND RESTATED MARKETING AGREEMENT (Emergent BioSolutions Inc., Filed With SEC on August 14, 2006)
- RXPEDITE ACORDA MARKETING SERVICES AGREEMENT (Acorda Therapeutics, Filed With SEC on November 28, 2003)
- RXPEDITE ACORDA MARKETING SERVICES AGREEMENT (Acorda Therapeutics, Filed With SEC on September 29, 2003)
- Ex 10.48 Antegren Development and Marketing Coll (Biogen Inc., Filed With SEC on March 14, 2003)
- MARKETING AGREEMENT (CYTRX CORP, Filed With SEC on November 14, 2002)
